The relationship between cancer surgery, lymph nodes, T cells and immunotherapy.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1144209

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cancer treatment involves surgery for millions of patients annually, however, many patients do relapse. Surgery often involves removal of cancer-associated lymph nodes at the site. To improve surgical outcomes new immunotherapy strategies aim to activate the patients’ immune cells to eradicate tumours. However the main repository for these immune cells is in the very lymph tissue removed at surgery. This project will investigate the role of remaining lymph nodes in patient recovery/response.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $960,585.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cells | cancer immunotherapy | lymph node | metastases | surgery

Related Links